Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin on Pro-Social Behavior in Social Anxiety Disorder
NCT01856530Phase 2Completed
- Start
- Jul 2012
- Primary completion
- Aug 2013
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of oxytocin nasal spray in Social Anxiety Disorder (SAD) (2 arms). Primary endpoints: Social Cooperation at Day 1 and Disengagement From Social Threat Cues at Day 1. Started Jul 2012; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT01856530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01856530.